ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,332, issued on June 17, was assigned to Novozymes A/S (Bagsvaerd, Denmark) and Novozymes Inc. (Davis, Calif.).
"GH61 variants and polynucleotides encoding same" was invented by Janine Lin (Davis, Calif.), Doreen Bohan (Fairfield, Calif.), Michelle Maranta (Davis, Calif.), Leslie Beresford (Roseville, Calif.), Michael Lamsa (Woodland, Calif.), Matt Sweeney (Sacramento, Calif.), Mark David Wogulis (Davis, Calif.), Elizabeth Znameroski (Davis, Calif.) and Frank Winther Rasmussen (Roskilde, Denmark).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to GH61 polypeptide variants. The present invention also relates to polynucleoti...